Open Access

Introduction - Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death.

Congress Session

About the speaker

Doctor Giovanni Luca Botto

ASST Rhodense, Garbagnate Milanese (Italy)
11 presentations
0 follower

4 more presentations in this session

Distilling the clinical evidence behind the WCD - What have clinical trials and registries told us?

Speaker: Doctor S. Reif (Munich, DE)

Thumbnail

Strategies for screening and identifying which patients to protect with the WCD.

Speaker: Professor J. Ehrlich (Wiesbaden, DE)

Thumbnail

The impact of the WCD for patients who choose to wear it.

Speaker: Professor D. Scherr (Graz, AT)

Thumbnail

Panel discussion and summary - Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death.

Speaker: Doctor O. Piot (Saint Denis, FR)

Thumbnail

Access the full session

Who should receive the Wearable Cardioverter Defibrillator (WCD)? Evidence and risk stratification for prevention of sudden cardiac death

Speakers: Doctor G. Botto, Doctor S. Reif, Professor J. Ehrlich, Professor D. Scherr, Doctor O. Piot
Thumbnail

About the event

Image

EHRA 2019

17 March - 19 March 2019

Sessions Presentations

Related content

Open Access

Challenges in SCD risk stratification.

28 August 2021

Open Access

Wearable devices and their role in sub-clinical arrhythmia detection.

28 August 2021

This platform is supported by

logo Novo Nordisk